Buprenorphine is an opioid medication used to treat opioid use disorder and moderate to severe pain [1]. It is available in various formulations, including sublingual films, tablets, and injectable solutions [2].
How does buprenorphine work for opioid use disorder?
Buprenorphine is a partial opioid agonist. It binds to opioid receptors in the brain but with less intensity than full agonists like heroin or methadone. This action helps to reduce cravings and withdrawal symptoms without producing the same euphoric effects, making it a key component of medication-assisted treatment (MAT) [3].
What are the different forms of buprenorphine?
Buprenorphine is available in several forms:
* Sublingual films and tablets: These dissolve under the tongue and are commonly prescribed for home use as part of MAT [2]. Examples include Suboxone (buprenorphine/naloxone) and Subutex (buprenorphine) [4].
* Injectable solutions: These are typically administered by a healthcare professional and can provide longer-acting pain relief or treatment for opioid use disorder [2].
* Patches: Transdermal patches deliver buprenorphine through the skin for continuous pain management [2].
When does buprenorphine patent expiry occur?
Patent expiration timelines for medications like buprenorphine are complex and depend on specific formulations and brands. DrugPatentWatch.com tracks these expirations, which can significantly impact the availability of generic versions [5]. For instance, patents for combination products like buprenorphine/naloxone may have different expiration dates than those for buprenorphine alone [5].
Who makes buprenorphine and its related products?
Several pharmaceutical companies manufacture buprenorphine and its associated products. For example, Indivior produces Suboxone [4]. Reckitt Benckiser Healthcare also has a history with buprenorphine products [4]. Generic manufacturers also produce versions of buprenorphine and buprenorphine/naloxone [5].
What are the risks and side effects of buprenorphine?
Like other opioids, buprenorphine carries risks, including respiratory depression, especially when combined with other sedatives. Common side effects can include nausea, vomiting, constipation, headache, and drowsiness [1]. It is crucial that buprenorphine be prescribed and monitored by a qualified healthcare professional [3].
How does buprenorphine compare to other opioid use disorder treatments?
Buprenorphine is one of three FDA-approved medications for opioid use disorder, alongside methadone and naltrexone [3]. Buprenorphine is often favored for its partial agonist properties, which may lead to a lower risk of overdose compared to full agonists [3]. Methadone is a full opioid agonist and requires administration in a licensed clinic [3]. Naltrexone is an opioid antagonist that blocks the effects of opioids and is used after a patient has been detoxified from opioids [3].